SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

A project grown out of the community's love and passion for the weed culture. Launched around early 2025, $weedcoin, “Like Bitcoin but way higher,” emphasizes its alignment with cannabis culture and a laid-back vibe. Unlike other Weed communities, this project leans heavily into community engagement over technical utility, aiming to build a “stoner community” through social media presence and decentralized governance. We also aim to focus on onboarding web2 businesses and users onto web3 through the token.

Weedcoin

Weedcoin is trending as the community rallies around the self-proclaimed "culture coin," drawing comparisons to Bitcoin. Active discussion includes references to a coin burn, website, roadmap, and community channels. Some users are also comparing it to other coins in the space.

Q/C Technologies, Inc. operates as a clinical-stage pharmaceutical company, which engages in the development of drug products to extend healthy lifespan. It focuses on developing two novel therapeutic platforms, MyMD-1 and SUPERA-CBD, which aim to treat the causes of disease rather than just addressing the symptoms. MyMD-1 is a clinical-stage small molecule that regulates the immune system to control TNF-a, which drives chronic inflammation, and other pro-inflammatory cytokines. SUPERA-CBD is a synthetic derivative of cannabidiol being developed to treat conditions such as epilepsy, chronic pain, depression, as well as neuroinflammatory and neurodegenerative diseases. The company was founded in 1989 and is headquartered in New York, NY.

Q/C Technologies Inc.

QCLS is trending due to its pivot towards quantum computing for cryptocurrency applications, generating excitement around energy-efficient blockchain infrastructure. The community is discussing the potential of LightSolver's laser-based processing units and comparing QCLS to other quantum and crypto-related stocks like $BTTC. Traders are monitoring the stock's threshold list status and anticipating news regarding partnerships and potential contract announcements.

Rigetti Computing, Inc. provides full-stack quantum computing services. It serves global enterprise, government, and research clients through its Rigetti Quantum Cloud Services platform. The company was founded by Chad Rigetti in 2013 and is headquartered in Berkeley, CA.

Rigetti Computing Inc

RGTI is trending due to increased interest in the quantum computing sector, amplified by news of government contracts and private sales. Community discussions revolve around the company's high valuation relative to current revenue, creating a debate between bullish long-term potential and bearish overvaluation concerns. Recent price action and volume spikes are also contributing to the stock's increased visibility.

D-Wave Quantum, Inc. engages in the development and delivery of quantum computing systems, software, and services. It provides customers with access to the company’s quantum computing systems via the cloud in the form of quantum computing as a service. It offers professional services such as customer assistance in identifying and implementing quantum-computing applications. The company was founded on January 25, 2022 and is headquartered in Palo Alto, CA.

D-Wave Quantum Inc

D-Wave Quantum (QBTS) is trending as the quantum computing sector gains momentum, with community members discussing the company's potential and recent developments like Comcast's partnership and police response time improvements. Discussions revolve around the company's technology, potential acquisitions, and government contracts, with some comparing it to the dot-com bubble while others see tangible value in AI integration. Despite mixed sentiment, bullish investors are anticipating a squeeze and see long-term potential, while bears express concerns about valuation and revenue.

IonQ, Inc. develops and manufactures quantum computers. The firm specializes in quantum computing and quantum information processing. The company was founded by Christopher Monroe and Jung Sang Kim in 2015 and is headquartered in College Park, MD.

IonQ Inc

IONQ is trending amidst discussions about its valuation and potential short squeeze, with some community members citing collaborations and government initiatives as catalysts.  The stock's high volatility is sparking debate between bulls predicting further upside and bears pointing to cash burn and dilution concerns. Overall, conversation centers on whether IONQ can justify its valuation in the rapidly evolving quantum computing sector.

$WAGMI is a community-driven meme token built on the Solana blockchain, designed to bring positivity, unity, and humor into the crypto space. The project encourages community engagement through memes, social interaction, and token-based activities. It leverages Solana’s fast and low-cost infrastructure to allow for smooth on-chain interactions, such as token transfers, community games, and NFT integration. The goal is to foster a fun, inclusive ecosystem where holders feel they are part of a larger movement – "We Are Gonna Make It."

WAGMI

WAGMI is trending as community members express strong conviction and positivity around the project's potential, especially within the $SOL ecosystem. Discussions highlight WAGMI's strong community, resilient price action, and potential for significant growth, with many believing "we're all gonna make it."

Rumble, Inc. engages in operating an online neutral video platform. It operates through the following geographical segments: United States, Canada, and Other. The company was founded in October 2013 by Chris Pavlovski and is headquartered in Longboat Key, FL.

Rumble Inc - Ordinary Shares - Class A

Rumble Inc

Rumble Inc. is trending following the announcement of its partnership with AI search engine Perplexity, aimed at improving video discovery on the platform. Community members are discussing the potential benefits of integrating AI tools and Rumble's ties to the crypto world, with some speculating on the impact of this collaboration and potential future acquisitions. The stock's high short interest is also a hot topic, with some anticipating a potential squeeze.

A multi-agent AI platform dissecting human nature’s first principles through iterative survival challenges and data-driven insights. Core dev has access to one of the founding partners of Two Sigma Ventures - the VC company of one of the biggest hedge funds in the world. Plans to raise seed round and scale after building organic foundation. Project devs are from academia space and are trying to bridge the gap between crypto and academia.

CortexZero

CortexZero is gaining attention as community members highlight its potential for a breakout, pointing to increased liquidity and strong buying activity. Conversations suggest a groundswell of support from early entrants, with many encouraging others to invest via Phantom Wallet. However, some users are also raising concerns about the token's concentration and low market cap.

Aster is a next-generation decentralized exchange offering both Perpetual and Spot trading, designed as a one-stop onchain venue for global crypto traders. It features MEV-free, one-click execution in Simple Mode. Pro Mode adds 24/7 stock perpetuals, Hidden Orders, and grid trading, available across BNB Chain, Ethereum, Solana, and Arbitrum.  Its unique edge lies in the ability to offer liquid-staking tokens (asBNB) or yield-generating stablecoins (USDF) as collateral, unlocking unparalleled capital efficiency. Powered by Aster Chain, a high-performance and privacy-focused L1, and backed by YZi Labs, Aster is building the future of DeFi: fast, flexible, and community-first.  At the heart of this ecosystem is the $ASTER token, a core asset that decentralizes governance, drives growth, rewards participation, and supports long-term sustainability.

ASTERION

ASTERION ($ASTER) is trending amid discussions about potential Binance listings and CZ's involvement, with some traders speculating about market manipulation and shorting opportunities. The community is actively debating price movements, airdrops, and whether ASTER can mirror the success of other perp DEXs, while also mentioning potential links to SAPIEN AI. Recent price volatility is fueling both bullish and bearish sentiments.

GameStop Corp. engages in offering games and entertainment products through its ecommerce properties and stores. The firm’s stores and ecommerce sites operate primarily under the names GameStop, EB Games, and Micromania. It operates through the following geographical segments: United States, Canada, Australia, and Europe. The company was founded by Daniel A. DeMatteo in 1996 and is headquartered in Grapevine, TX.

Gamestop Corporation - Ordinary Shares - Class A

GameStop Corp

GameStop is trending as investors discuss the implications of the upcoming warrant distribution and its potential impact on the stock price, with many anticipating volatility and a possible short squeeze. Community members are debating strategies around buying, holding, and exercising warrants, while others express frustration with the company's management and perceived market manipulation. Amidst the mixed sentiment, the conversation is lively with speculation about potential catalysts and the stock's long-term prospects within the broader meme stock landscape.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Beat the Market the Zacks Way: Helios Technologies, InterDigital, UnitedHealth in Focus

Helios Technologies, InterDigital and UnitedHealth shine as Zacks' strategies deliver strong gains across model portfolios.

CDTX Stock Soars 218% YTD on Positive Updates From Influenza Program

Cidara Therapeutics' shares surge 218% this year after its flu candidate CD388 hits key mid-stage study goals and advances into pivotal testing.

QURE Stock Skyrockets on Meeting Goals in Huntington's Disease Study

uniQure N.V. shares surge nearly 248% after its gene therapy candidate, AMT-130, met key goals in a pivotal Huntington's disease study.

ACAD Stock Down 10% Following Phase III Hyperphagia Study Failure

Acadia Pharmaceuticals stock tumbles 10% after its phase III hyperphagia study failure, but growth remains driven by Nuplazid, Daybue and a robust pipeline.

REPL Stock Plunges 54% in 3 Months After FDA Rejects Skin Cancer Drug

Replimune stock dives 54% over three months after the FDA rejects its RP1/Opdivo melanoma drug filing, delaying its first potential product launch.

Zacks Industry Outlook Highlights Halozyme Therapeutics, Akero Therapeutics, Kiniska Pharmaceuticals, ANI Pharmaceuticals and Twist BioScience

Biotech stocks gain momentum as M&A, AI-driven drug discovery, and new approvals fuel growth; Halozyme, Akero, Kiniska, ANI and Twist stand out.

5 Biotech Stocks Worth Adding to Your Portfolio Now 

New drug approvals and encouraging pipeline progress should maintain momentum in the Zacks Biomedical and Genetics industry despite the uncertain macroeconomic environment. A strong portfolio and solid pipeline progress position HALO, AKRO, KSNA, ANIP and TWST in this volatile sector

SNY & REGN's Dupixent Receives CHMP Backing for Urticaria in EU

Sanofi/Regeneron's Dupixent wins CHMP backing for chronic spontaneous urticaria in the EU, paving the way for expanded treatment options.

FDA Extends Review Period of Sanofi's Multiple Sclerosis Drug Filing

The FDA extends SNY's tolebrutinib NDA review by three months, with decision now expected on Dec. 28, 2025.

Kiniksa Pharmaceuticals International, plc (KNSA) is on the Move, Here's Why the Trend Could be Sustainable 

If you are looking for stocks that are well positioned to maintain their recent uptrend, Kiniksa Pharmaceuticals International, plc (KNSA) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.

Kiniksa Pharmaceuticals International Plc is a commercial-stage biopharmaceutical company. It engages in discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical need. The company was founded on April 9, 2024 and is headquartered in London, United Kingdom.

Kiniksa Pharmaceuticals International Plc. - Ordinary Shares - Class A

0 to 25,000

25,000 to 50,000

50,000 to 75,000

75,000 to 100,000

How many jobs did the U.S. add in September? Vote below + drop your exact prediction in the comments. 
 
*Powered by Polymarket

Current Price	$37.47
Prev Close	$38.64
Open	$38.41
Dividend Yield	0.00%
50-Day Moving Average	$33.90
Beta	0.74
Avg. Volume	440,054.38
PE Ratio	940.15

52-Week High	$39.12
52-Week Low	$17.82
Market Capitalization	$2.86B
EPS (Annual)	-$0.6047
Price to Book	5.78
Revenue Per Employee	$1.34M
Enterprise Value/EBITDA	N/A

KNSA
Kiniksa Pharmaceuticals Ltd - Ordinary Shares - Class A

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest KNSA News

KNSA Kiniksa Pharmaceuticals Ltd - Ordinary Shares - Class A